![conference banner](/images/conference-banner.jpeg)
Abstract
Several findings suggest that patient outcome would be improved with individualized doses. The aim of this paper is to describe major approaches, methods and underlying basic foundations implemented, in clinical practice, for dosage individualization. Also we propose a new method codified by kinetic nomograms as reliable alternative to traditional Bayesian methods. Clinical and simulation data were reported to evaluate performances of the proposed methods. Real examples of therapeutic drug monitoring were selected. Bayesian methods were used to individualize high-dose methotrexate rate infusion and amikacin dosage regimen, and kinetic nomograms to adjust sirolimus doses. 1) Using only few measurements, Bayesian method resulted in accurate estimates of individual pharmacokinetic parameters of highdose methotrexate infusion. Targeting a pre-defined end-of-infusion level, infusion rate was individualized according to the previously obtained pharmacokinetic parameters. 2) With the same reasoning, individual pharmacokinetic parameters of amikacin were obtained by Bayesian estimation using three individual samples. Subsequent dosage adjustment allowed achievement of therapeutic goals at steady state. 3) Without computing individual pharmacokinetic parameters, nor using pharmacokinetic software, kinetic nomograms steered individual sirolimus blood levels within its therapeutic window with only two samples and in the first week after starting treatment. This contribution relates traditional Bayesian methods developed in 80’s but not yet fully integrated in clinical context because of their complexity. The contribution focuses on recent developments based on population approaches, rendering the dosage adjustment methodology a simple and quick bedside application.
Keywords: Bayesian estimation, dosage adjustment, inter-individual variability, pharmacokinetics, population approaches, therapeutic drug monitoring
Current Topics in Medicinal Chemistry
Title:Progress in Strategies for Dosage Regimen Individualization
Volume: 12 Issue: 15
Author(s): Hafedh Marouani, Christian Woloch, Stephan Benay, Nicolas Frances and Athanassios Iliadis
Affiliation:
Keywords: Bayesian estimation, dosage adjustment, inter-individual variability, pharmacokinetics, population approaches, therapeutic drug monitoring
Abstract: Several findings suggest that patient outcome would be improved with individualized doses. The aim of this paper is to describe major approaches, methods and underlying basic foundations implemented, in clinical practice, for dosage individualization. Also we propose a new method codified by kinetic nomograms as reliable alternative to traditional Bayesian methods. Clinical and simulation data were reported to evaluate performances of the proposed methods. Real examples of therapeutic drug monitoring were selected. Bayesian methods were used to individualize high-dose methotrexate rate infusion and amikacin dosage regimen, and kinetic nomograms to adjust sirolimus doses. 1) Using only few measurements, Bayesian method resulted in accurate estimates of individual pharmacokinetic parameters of highdose methotrexate infusion. Targeting a pre-defined end-of-infusion level, infusion rate was individualized according to the previously obtained pharmacokinetic parameters. 2) With the same reasoning, individual pharmacokinetic parameters of amikacin were obtained by Bayesian estimation using three individual samples. Subsequent dosage adjustment allowed achievement of therapeutic goals at steady state. 3) Without computing individual pharmacokinetic parameters, nor using pharmacokinetic software, kinetic nomograms steered individual sirolimus blood levels within its therapeutic window with only two samples and in the first week after starting treatment. This contribution relates traditional Bayesian methods developed in 80’s but not yet fully integrated in clinical context because of their complexity. The contribution focuses on recent developments based on population approaches, rendering the dosage adjustment methodology a simple and quick bedside application.
Export Options
About this article
Cite this article as:
Marouani Hafedh, Woloch Christian, Benay Stephan, Frances Nicolas and Iliadis Athanassios, Progress in Strategies for Dosage Regimen Individualization, Current Topics in Medicinal Chemistry 2012; 12 (15) . https://dx.doi.org/10.2174/156802612803531315
DOI https://dx.doi.org/10.2174/156802612803531315 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Correlation of CYP2B6-516G>T Polymorphism with Plasma Efavirenz Concentration and Depression in HIV-Infected Adults in Northern Thailand
Current HIV Research Recent Major Advances of Biotechnology and Sustainable Aquaculture in China
Current Biotechnology Incretin-Based Therapies in Patients with Type 2 Diabetes
Current Drug Therapy Telomere/Telomerase System: A New Target of Statins Pleiotropic Effect?
Current Vascular Pharmacology <i>N</i>-Acylhydrazone Pharmacophore's Analgesic and Anti-inflammatory Profile: Recent Advancements during the Past Ten Years
Current Pharmaceutical Design An Update on Herbal Anti-inflammatory Agents in Periodontal Therapy
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy Silica Sulfuric Acid and Related Solid-supported Catalysts as Versatile Materials for Greener Organic Synthesis
Current Organic Synthesis An Overview of Biosynthetic Pathway and Therapeutic Potential of Naringin
Current Indian Science Need for Nutritious Convenience Foods for the Elderly Population: A Review
Current Nutrition & Food Science Pharmacologic Role of Vitamin D Natural Products
Current Vascular Pharmacology A Comprehensive Review on Exosomes and Microvesicles as Epigenetic Factors
Current Stem Cell Research & Therapy Novel Action and Mechanism of Auranofin in Inhibition of Vascular Endothelial Growth Factor Receptor-3-Dependent Lymphangiogenesis
Anti-Cancer Agents in Medicinal Chemistry The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature
Current Diabetes Reviews NPFF2 Receptor is Involved in the Modulatory Effects of Neuropeptide FF for Macrophage Cell Line
Protein & Peptide Letters Pharmacological Modulation of Nitric Oxide Release: New Pharmacological Perspectives, Potential Benefits and Risks
Current Medicinal Chemistry Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Malnutrition could Predict 3-month Functional Prognosis in Mild Stroke Patients: Findings from a Nationwide Stroke Registry
Current Neurovascular Research Aptamers in Drug Design: An Emerging Weapon to Fight a Losing Battle
Current Drug Targets Nutraceuticals - An Emerging Era in the Treatment and Prevention of Cardiovascular Diseases
Current Pharmaceutical Biotechnology